These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1723126)

  • 21. [Arrhythmias during pregnancy].
    Trappe HJ
    Dtsch Med Wochenschr; 2008 Sep; 133(36):1799-804. PubMed ID: 18767007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hybrid therapy of atrial fibrillation.
    Santini M; Pignalberi C; Ricci R; Calò L
    Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The management of cardiac arrhythmias.
    Hampton JR
    Br J Hosp Med; 1977 Feb; 17(2):160-2, 165, 167-72. PubMed ID: 870118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [What information is given by controlled clinical trials (pharmacological and nonpharmacological) for anti-arrhythmia therapy in the prevention of sudden death?].
    Naccarella F; Croci F
    G Ital Cardiol; 1996 Nov; 26(11):1345-64. PubMed ID: 9036037
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prevention of complications: a forgotten aspect of therapy? arrhythmia complication in heart failure].
    de Sousa J
    Rev Port Cardiol; 2001 Mar; 20 Suppl 3():33-8. PubMed ID: 11409072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-tachycardia stimulation in supraventricular and ventricular tachycardia with and without cardioverter/defibrillator].
    Klein H
    Herz; 1991 Jun; 16(3):182-98. PubMed ID: 1889793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of electrostimulation in the treatment of tachycardia].
    Kappenberger L
    Schweiz Med Wochenschr; 1982 Nov; 112(45):1571-3. PubMed ID: 7156948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy of ventricular arrhythmias].
    Frohner K
    Wien Med Wochenschr; 1984 Oct; 134(19-20):448-57. PubMed ID: 6516421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of malignant ventricular arrhythmias using antitachycardia devices.
    McCowan RJ; Sampath R; Lee KC; Rashid H; Cafoncelli AR; Khan ZM; Malik FS; Chapman JL; Figueroa E; Freund PE
    W V Med J; 1991 Sep; 87(9):395-9. PubMed ID: 1949755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathophysiological mechanism of cardiac arrhythmias as a key for optimal nonpharmacological treatment.
    Kozluk E
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 11():69-77. PubMed ID: 17244939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do we need new antiarrhythmic compounds in the era of implantable cardiac devices and percutaneous ablation?
    Christ T; Ravens U
    Cardiovasc Res; 2005 Dec; 68(3):341-3. PubMed ID: 16256089
    [No Abstract]   [Full Text] [Related]  

  • 32. [Malignant ventricular hyperkinetic arrhythmia: role of permanent electric treatment].
    Pistolese M; Boccadamo R; Altamura G; Toscano S; Broglia R; Lo Bianco F; Serdoz R; Greco EM; Lotto A
    G Ital Cardiol; 1983; 13(4):315-7. PubMed ID: 6884676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post automatic implantable cardioverter defibrillator implant therapies: drugs and ablative techniques.
    Colella A; Pieragnoli P; Ricciardi G; Giaccardi M; Padeletti L; Michelucci A
    Minerva Cardioangiol; 2007 Jun; 55(3):341-51. PubMed ID: 17534253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the treatment of arrhythmias: implantable cardioverter-defibrillators.
    Groh WJ; Foreman LD; Zipes DP
    Am Fam Physician; 1998 Jan; 57(2):297-307, 310-2. PubMed ID: 9456993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of implantable pacemakers in the therapy of tachycardias.
    Furman S; Pannizzo F
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():29-34. PubMed ID: 3938255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drug therapy of cardiac arrhythmias 199].
    Dietz A; Manz M
    Fortschr Med; 1997 Nov; 115(33):32, 34-6, 38. PubMed ID: 9480278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
    Klein MH; Gold MR
    Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiarrhythmic therapy in heart failure.
    Eckardt L; Haverkamp W; Breithardt G
    Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ventricular arrhythmias and sudden cardiac death].
    Abuladze GV; Nevieridze MI; Abashidze RI; Gabarashvili LV; Kvirkveliia AA
    Georgian Med News; 2009 Mar; (168):50-3. PubMed ID: 19359720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current clinical therapy of tachycardiac arrhythmias].
    Bleifeld W
    Dtsch Med J; 1971 May; 20(10):309-16. PubMed ID: 4105612
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.